Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$15,559,007
+$3,636,029 QoQ
Shares Held
12,972
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.60%
of 13F equity value
Holder Rank
#1,017
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellington Shields & Co., LLC holds $37,282,872 across 9 Drug Manufacturers - General names. LLY ranks #1 (41.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
12,972 | $15,559,007 | |
| 2 | ABBV |
AbbVie Inc.
|
30,747 | $7,737,175 | |
| 3 | JNJ |
Johnson & Johnson
|
17,288 | $4,390,633 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,666 | $2,912,581 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
39,424 | $2,271,610 | |
| 6 | PFE |
Pfizer Inc
|
74,795 | $1,801,063 | |
| 7 | AMGN |
Amgen Inc
|
4,929 | $1,784,889 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,963 | $753,365 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,559,007 | 12,972 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $11,922,978 | 12,963 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $13,946,123 | 12,977 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,781,660 | 12,820 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,950,700 | 12,765 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $10,630,287 | 12,871 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $10,217,420 | 13,235 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $11,991,197 | 13,535 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,255,223 | 13,536 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,682,946 | 13,732 | Shares | Sole | 2024-05-23 | |
| 2023-12-31 | $7,934,707 | 13,612 | Shares | Sole | 2024-05-23 | |
| 2023-09-30 | $7,084,207 | 13,189 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,500,062 | 13,860 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,738,852 | 13,799 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,043,836 | 13,787 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,431,188 | 13,704 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,683,178 | 14,444 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,534,096 | 15,833 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,370,076 | 15,821 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,652,669 | 15,809 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,671,860 | 15,998 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,986,504 | 15,986 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,950,141 | 17,473 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,598,935 | 17,558 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,880,045 | 17,542 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,445,078 | 17,626 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||